Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Mar-22 5:56 PM View:  | Revance Therapeutics, Inc. (RVNC) | 15-Mar-22 | Payment of Exercise | 2,607 | $15.79 | $41,164.50 | (2%) 123.31K to 120.71K | 2% |
| 17-Feb-22 8:51 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-22 | Payment of Exercise | 5,053 | $13.35 | $67,457.60 | (4%) 128.37K to 123.31K | |
| 17-Mar-21 7:27 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-21 | Payment of Exercise | 1,354 | $27.73 | $37,546.40 | (1%) 129.72K to 128.37K | (< 1%) |
| 19-Feb-21 8:10 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-21 | Payment of Exercise | 4,848 | $28.97 | $140,447.00 | (4%) 134.57K to 129.72K | 3% |
| 04-Feb-21 9:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-21 | Grant | 22,620 | -- | -- | 20% 111.95K to 134.57K | |
| 02-Oct-20 8:31 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Grant | 17,500 | -- | -- | 17% 101.83K to 119.33K | |
| 02-Oct-20 8:31 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Payment of Exercise | 7,382 | $25.14 | $185,583.00 | (6%) 119.33K to 111.95K | (10%) |
| 17-Mar-20 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-20 | Payment of Exercise | 1,354 | $15.50 | $20,987.00 | (1%) 103.19K to 101.83K | (78%) |
| 19-Feb-20 8:22 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-20 | Payment of Exercise | 3,325 | $25.33 | $84,222.20 | (3%) 106.51K to 103.19K | (9%) |
| 24-Jan-20 8:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Jan-20 | Grant | 25,000 | -- | -- | 31% 81.51K to 106.51K | |
| 17-Jan-20 8:12 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Jan-20 | Payment of Exercise | 4,441 | $22.89 | $101,654.00 | (5%) 85.95K to 81.51K | (20%) |
| 17-Dec-19 7:56 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Dec-19 | Payment of Exercise | 2,971 | $15.99 | $47,506.30 | (3%) 88.92K to 85.95K | (73%) |
| 18-Mar-19 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-19 | Payment of Exercise | 1,354 | $15.45 | $20,919.30 | (1%) 90.28K to 88.92K | (79%) |
| 18-Mar-19 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Mar-19 | Payment of Exercise | 166 | $15.59 | $2,587.94 | (< 1%) 90.44K to 90.28K | (77%) |
| 18-Mar-19 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Mar-19 | Option Exercise | 666 | $4.20 | $2,797.20 | < 1% 89.78K to 90.44K | |
| 20-Feb-19 9:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-19 | Payment of Exercise | 1,510 | $17.69 | $26,711.90 | (2%) 91.29K to 89.78K | (56%) |
| 25-Jan-19 8:49 PM View: | Revance Therapeutics, Inc. (RVNC) | 24-Jan-19 | Grant | 15,750 | -- | -- | 21% 75.54K to 91.29K | |
| 17-Jan-19 8:55 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Jan-19 | Payment of Exercise | 4,466 | $20.19 | $90,168.50 | (6%) 80.0K to 75.54K | (37%) |
| 14-Dec-18 9:23 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Dec-18 | Payment of Exercise | 4,260 | $19.91 | $84,816.60 | (5%) 84.26K to 80.0K | (39%) |
| 23-Mar-18 9:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 21-Mar-18 | Option Exercise | 666 | $2.55 | $1,698.30 | < 1% 83.6K to 84.26K | |
| 16-Feb-18 7:44 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-18 | Payment of Exercise | 1,509 | $31.75 | $47,910.80 | (2%) 85.11K to 83.6K | 13% |
| 09-Feb-18 9:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 08-Feb-18 | Grant | 11,750 | -- | -- | 16% 73.36K to 85.11K | |
| 17-Jan-18 9:51 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Jan-18 | Payment of Exercise | 4,327 | $34.50 | $149,282.00 | (6%) 77.68K to 73.36K | 20% |
| 18-Dec-17 8:26 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Dec-17 | Payment of Exercise | 3,229 | $32.15 | $103,812.00 | (4%) 80.91K to 77.68K | 14% |
| 30-Jan-17 9:25 PM View: | Revance Therapeutics, Inc. (RVNC) | 26-Jan-17 | Grant | 13,100 | -- | -- | 19% 67.81K to 80.91K | |
| 16-Dec-16 7:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-16 | Grant | 36,000 | -- | -- | 113% 31.81K to 67.81K | |
| 16-Dec-16 7:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Dec-16 | Payment of Exercise | 3,229 | $16.70 | $53,924.30 | (9%) 35.04K to 31.81K | |
| 16-Aug-16 8:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 12-Aug-16 | Option Exercise | 666 | $6.60 | $4,395.60 | 2% 34.38K to 35.04K | |
| 16-Dec-15 6:59 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Dec-15 | Grant | 34,375 | -- | -- | 100% 0 to 34.38K |